In Exubera's Shadow: Generex Bets Oral Spray Is Next Big Thing for Diabetics

•  
  raytayzmd10/01/08 Report as spam
  1

  RE: In Exubera's Shadow: Generex Bets Oral Spray Is Next Big Thing for Diabetics

  ..."What do you think?"...well, right now I think you are either one dumb, gullible SOB or else you're on GNBT's payroll...absorption of oralyn's insulin is only about five per cent...a canister of oralyn contains enough insulin to last an averge diabetic IF it were INJECTED...but because of the pitiful absorption, a cannister will last the average diabetic no more than day or two...and have you looked at their last 10Q?...revenues were less than 2,000 dollars!...and that despite having oralyn plus several other "products" on the market...the company has been run solely for the purpose of enriching management...fortunately, it appears that is about to come to a close since they're running out of money and have a "death spiral" convertible slowly but steadily burying the stock...

•  
  raytayzmd10/01/08 Report as spam
  2

  RE: In Exubera's Shadow: Generex Bets Oral Spray Is Next Big Thing for Diabetics

  ...correction of prevoius post:
  
  "canister of oralyn contains enough insulin to last an averge diabetic a MONTH if it were INJECTED...but because of the pitiful absorption, a cannister"

•  
  dh4systems12/06/08 Report as spam
  3

  RE: In Exubera's Shadow: Generex Bets Oral Spray Is Next Big Thing for Diabetics

  Thank you again to Dr. Berstein, a previous President of the ADA for his leadership in helping diabetics, young and old, in finding a better, more comvenient, safer way of taking insulin.
  
  Oral-lyn has much going for it, especially with it's ties to Shreya in India. This will be the proving grounds for a world wide solution for juvinile diabetes, where refrigeration is not needed, where the use of needles will not be needed during mealtimes.
  
  Generics (GNBT) is working on a total package solution to help those with diabetes and those with a family history of diabetes. By addressing the problem in pre-diabetes, Generex hopes to delay to onslaught of multiple effects of this terrible, world-wide, problem.
  
  Recently Generex announced Met-Control, a gum delivery form of metformin to address the side effects of tablet based metformin.
  
  Sad to say "raytayzmd" would not to see Generex Bioltechnology succeed in helping diabetics worldwide. For those that would prefer injecting themselves over a simple spray, like an asthma-like device, then they have no reson to change. However, when now given a choice, injection one again by needle or a simple spray into the cheeks, Oral-lyn is on the right track.
  
  The high level of non-compliance of treatment due to rejection of injecting oneself, especially in children and teens, is too high to ignore and Oral-lyn provides a wonderful, safe alternative.